The use of a TLR2 agonist-based adjuvant for enhancing effector and memory CD8 T-cell responses
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The use of a TLR2 agonist-based adjuvant for enhancing effector and memory CD8 T-cell responses
Authors
Keywords
-
Journal
IMMUNOLOGY AND CELL BIOLOGY
Volume 92, Issue 4, Pages 377-383
Publisher
Wiley
Online
2014-01-07
DOI
10.1038/icb.2013.102
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular Pathways: Toll-like Receptors in the Tumor Microenvironment--Poor Prognosis or New Therapeutic Opportunity
- (2012) L. A. Ridnour et al. CLINICAL CANCER RESEARCH
- Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8+T-cell responses in melanoma patients
- (2012) Simone M. Goldinger et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Mycobacterium tuberculosis Rv0577, a novel TLR2 agonist, induces maturation of dendritic cells and drives Th1 immune response
- (2012) Eui-Hong Byun et al. FASEB JOURNAL
- Hepatitis C VLPs Delivered to Dendritic Cells by a TLR2 Targeting Lipopeptide Results in Enhanced Antibody and Cell-Mediated Responses
- (2012) Brendon Y. Chua et al. PLoS One
- Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity
- (2011) P. J. Tacken et al. BLOOD
- Protective T cell immunity in mice following protein-TLR7/8 agonist-conjugate immunization requires aggregation, type I IFN, and multiple DC subsets
- (2011) Kathrin Kastenmüller et al. JOURNAL OF CLINICAL INVESTIGATION
- Soluble Proteins Induce Strong CD8+ T Cell and Antibody Responses through Electrostatic Association with Simple Cationic or Anionic Lipopeptides That Target TLR2
- (2011) B. Y. Chua et al. JOURNAL OF IMMUNOLOGY
- Alum adjuvant: some of the tricks of the oldest adjuvant
- (2011) M. Kool et al. JOURNAL OF MEDICAL MICROBIOLOGY
- TLR2-Dependent Induction of IL-10 and Foxp3+CD25+CD4+ Regulatory T Cells Prevents Effective Anti-Tumor Immunity Induced by Pam2 Lipopeptides In Vivo
- (2011) Sayuri Yamazaki et al. PLoS One
- Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice
- (2011) Chung Truong Nguyen et al. VACCINE
- The synthetic TLR2 agonist BPPcysMPEG leads to efficient cross-priming against co-administered and linked antigens
- (2010) Chittappen K. Prajeeth et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The Capacity To Induce Cross-Presentation Dictates the Success of a TLR7 Agonist-Conjugate Vaccine for Eliciting Cellular Immunity
- (2010) J. Z. Oh et al. JOURNAL OF IMMUNOLOGY
- TLR2 Engagement on Dendritic Cells Promotes High Frequency Effector and Memory CD4 T Cell Responses
- (2009) S. S. Chandran et al. JOURNAL OF IMMUNOLOGY
- A critical role for direct TLR2-MyD88 signaling in CD8 T-cell clonal expansion and memory formation following vaccinia viral infection
- (2008) M. Quigley et al. BLOOD
- Engagement of Toll-like receptor-2 on cytotoxic T-lymphocytes occurs in vivo and augments antitumor activity
- (2008) Nicole Asprodites et al. FASEB JOURNAL
- Endogenous Naive CD8+ T Cell Precursor Frequency Regulates Primary and Memory Responses to Infection
- (2008) Joshua J. Obar et al. IMMUNITY
- A self-adjuvanting lipopeptide-based vaccine candidate for the treatment of hepatitis C virus infection
- (2008) Brendon Y. Chua et al. VACCINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started